Purica Enzymes
Natural health product licensed in Canada
- Licence holder
- Nutraceutical Medicine Company Inc.
- NPN or DIN-HM
- 80112285
- Status
- Active licence
- Licence date
- 20 August 2021
- Revision date
- 10 May 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus niger - En entier | 22.7 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus niger - En entier | 3,000 FCC DU | Not calculated |
| 4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier | 16.7 mg | Not calculated |
| 4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier | 15 Unité de glucoamylase du FCC | Not calculated |
| Protéase Source : Aspergillus niger - En entier | 500 FCC SAPU | Not calculated |
| Protéase Source : Aspergillus niger - En entier | 75,000 FCC HUT | Not calculated |
| Dipeptidyl aminopeptidase IV Source : Aspergillus flavus var. oryzae - Cellule entière | 125 FCC HUT | Not calculated |
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 56.3 mg | Not calculated |
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 4,500 FCC ALU | Not calculated |
| myo-Inositol-hexakisphosphate 3-phosphohydrolase Source : Aspergillus niger - En entier | 10 FCC FTU | Not calculated |
| myo-Inositol-hexakisphosphate 3-phosphohydrolase Source : Aspergillus niger - En entier | 4.2 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Maltodextrine, Dextrine, Triglycérides à chaîne moyenne
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Digestive enzyme(s). Digestive enzyme/lactase to assist in the digestion of foods containing lactose (e.g. dairy foods, milk). Helps prevent symptoms of lactose intolerance (including gas, bloating, cramping and diarrhea).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80112285
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging